Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients
Purpose: This study aims to determine the usage frequency of long-acting injectable antipsychotics among bipolar disorder type 1 patients who presented to the Dicle University Faculty of Medicine Psychiatry and Mental Health outpatient clinic, the clinical characteristics of these patients, and the...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cukurova University
2022-06-01
|
| Series: | Cukurova Medical Journal |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2314703 |
| _version_ | 1797908893489168384 |
|---|---|
| author | Derya Gül Bilen Abdullah Atlı Betül Uyar |
| author_facet | Derya Gül Bilen Abdullah Atlı Betül Uyar |
| author_sort | Derya Gül Bilen |
| collection | DOAJ |
| description | Purpose: This study aims to determine the usage frequency of long-acting injectable antipsychotics among bipolar disorder type 1 patients who presented to the Dicle University Faculty of Medicine Psychiatry and Mental Health outpatient clinic, the clinical characteristics of these patients, and the preferences of clinicians about these agents.
Materials and Methods: Our study included 111 patients older than 18 years old with bipolar disorder. The ’data of the patients were retrospectively obtained from electronic data records. The data were recorded in the data collection form prepared by the researchers with the support of the literature.
Results: The rate of the patients who used long-acting injectable antipsychotics was 21.6%. Among the patients who used long-acting injectable antipsychotics, the rate of those who used second-generation long-acting injectable antipsychotics was 58.3%, and the most frequently preferred agent was paliperidone palmitate. The patients who were using long-acting injectable antipsychotics had significantly higher rates of not working and numbers of hospitalizations.
Conclusion: Our results showed that long-acting injectable antipsychotics are preferred by clinicians in our outpatient clinic in the later stages of bipolar disorders and for patients with poor drug compliance, poor functionality, and more hospitalizations. Starting long-acting injectable antipsychotics in the early stages of bipolar disorders, even following the first attack, may increase treatment compliance, reduce the duration of hospitalization, and contribute to the functionality of patients. |
| first_indexed | 2024-04-10T11:00:03Z |
| format | Article |
| id | doaj.art-842c5b0deba34d598816065b5f939d7c |
| institution | Directory Open Access Journal |
| issn | 2602-3040 |
| language | English |
| last_indexed | 2024-04-10T11:00:03Z |
| publishDate | 2022-06-01 |
| publisher | Cukurova University |
| record_format | Article |
| series | Cukurova Medical Journal |
| spelling | doaj.art-842c5b0deba34d598816065b5f939d7c2023-02-15T16:19:45ZengCukurova UniversityCukurova Medical Journal2602-30402022-06-0147284485110.17826/cumj.108905948Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patientsDerya Gül Bilen0Abdullah Atlı1Betül Uyar2DICLE UNIVERSITY, SCHOOL OF MEDICINEDICLE UNIVERSITY, SCHOOL OF MEDICINEDICLE UNIVERSITY, SCHOOL OF MEDICINEPurpose: This study aims to determine the usage frequency of long-acting injectable antipsychotics among bipolar disorder type 1 patients who presented to the Dicle University Faculty of Medicine Psychiatry and Mental Health outpatient clinic, the clinical characteristics of these patients, and the preferences of clinicians about these agents. Materials and Methods: Our study included 111 patients older than 18 years old with bipolar disorder. The ’data of the patients were retrospectively obtained from electronic data records. The data were recorded in the data collection form prepared by the researchers with the support of the literature. Results: The rate of the patients who used long-acting injectable antipsychotics was 21.6%. Among the patients who used long-acting injectable antipsychotics, the rate of those who used second-generation long-acting injectable antipsychotics was 58.3%, and the most frequently preferred agent was paliperidone palmitate. The patients who were using long-acting injectable antipsychotics had significantly higher rates of not working and numbers of hospitalizations. Conclusion: Our results showed that long-acting injectable antipsychotics are preferred by clinicians in our outpatient clinic in the later stages of bipolar disorders and for patients with poor drug compliance, poor functionality, and more hospitalizations. Starting long-acting injectable antipsychotics in the early stages of bipolar disorders, even following the first attack, may increase treatment compliance, reduce the duration of hospitalization, and contribute to the functionality of patients.https://dergipark.org.tr/tr/download/article-file/2314703antipsychoticsbipolar disorderlong-acting injectable antipsychoticsbipolar disorderantipsychoticslong-actinglong-acting injectable |
| spellingShingle | Derya Gül Bilen Abdullah Atlı Betül Uyar Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients Cukurova Medical Journal antipsychotics bipolar disorder long-acting injectable antipsychotics bipolar disorder antipsychotics long-acting long-acting injectable |
| title | Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients |
| title_full | Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients |
| title_fullStr | Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients |
| title_full_unstemmed | Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients |
| title_short | Clinical use of long-acting antipsychotics for the treatment of bipolar disorder type I patients |
| title_sort | clinical use of long acting antipsychotics for the treatment of bipolar disorder type i patients |
| topic | antipsychotics bipolar disorder long-acting injectable antipsychotics bipolar disorder antipsychotics long-acting long-acting injectable |
| url | https://dergipark.org.tr/tr/download/article-file/2314703 |
| work_keys_str_mv | AT deryagulbilen clinicaluseoflongactingantipsychoticsforthetreatmentofbipolardisordertypeipatients AT abdullahatlı clinicaluseoflongactingantipsychoticsforthetreatmentofbipolardisordertypeipatients AT betuluyar clinicaluseoflongactingantipsychoticsforthetreatmentofbipolardisordertypeipatients |